Multiple Assemblies exist for SMTL entry 2op3
The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substrate Activity Screening (SAS) method; X-RAY DIFFRACTION 1.60 Å

	SMTL ID 2op3.1 Ligands SULFATE ION; 2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL Polypeptides Cathepsin S Oligo-state monomer
	SMTL ID 2op3.2 Ligands 2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL Polypeptides Cathepsin S Oligo-state monomer
	SMTL ID 2op3.3 Ligands SULFATE ION; 2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL Polypeptides Cathepsin S Oligo-state homo-tetramer
	SMTL ID 2op3.4 Ligands SULFATE ION; 2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL Polypeptides Cathepsin S Oligo-state homo-dimer